Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828210) titled 'NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: EVD Pharmacy and Medical Company Limited
Condition:
Stroke
Stroke, Acute Ischemic
Stroke, Ischemic
Stroke, Cryptogenic
Stroke, Cardiovascular
Intervention:
Drug: MLC901
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: September 10, 2026
Target Sample Size: 80
Countries of Recruitment:
Vietnam
To know more...